𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Invasive Aspergillosis in Patients with Hematologic Malignancies

✍ Scribed by Dr. Nathan P. Wiederhold; Dr. Russell E. Lewis; Dimitrios P. Kontoyiannis


Book ID
115048698
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
240 KB
Volume
23
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Liposomal amphotericin B in combination
✍ Denis Caillot; Anne ThiΓ©baut; Raoul Herbrecht; StΓ©phane de Botton; Arnaud Pigneu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a

Efficacy and toxicity of caspofungin in
✍ Dimitrios P. Kontoyiannis; Ray Hachem; Russell E. Lewis; Gustavo A. Rivero; Harr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e